Integration of nutritional support with paediatric HIV care in developing countries

CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

Volumn 7, Issue , 2012, Pages

  Semba, Richard D ^a   De Pee, Saskia ^b   Bloem, Martin W ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b World Food Programme   (Italy)

Author keywords

Acquired immune deficiency syndrome; Children; Food; Human immunodeficiency virus; Malnutrition; Micronutrient; Nutrition

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84868613617     PISSN: None     EISSN: 17498848     Source Type: Journal    
DOI: 10.1079/PAVSNNR20127057     Document Type: Review

References (84)

1. Joint United Nations Program on HIV/AIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic; 2010.
2. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Recommendations for a Public Health Approach. World Health Organization, Geneva; 2010.
3. World Health Organization. Manual on Paediatric Care and Treatment for District Hospitals. World Health Organization, Geneva; 2011.
4. Wilfert CM, Sripipatana T, Spensley A, Kieffer MP, Bitarakwate E. Prevention of vertical transmission of HIV in resourcelimited countries. Advances in Experimental Medicine and Biology 2011;697:41-57.
5. World Health Organization. Programmatic Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Executive Summary. World Health Organization, Geneva; 2012.
6. Schwartländer B, Stover J, Hallet T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011;377:2031-41.
7. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. New England Journal of Medicine 1981;305:1425-31. (Pubitemid 12240076)
8. Masur H, Michelis MA, Greene JB, Oronato I, Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. New England Journal of Medicine 1981;305:1431-8. (Pubitemid 12240077)
9. Siegal FP, Lopez C, Hammer GS, Browne AE, Kornfeld SJ, Gold J, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. New England Journal of Medicine 1981;305:1439-44. (Pubitemid 12240078)
10. Centers for Disease Control and Prevention (CDC). Update on acquired immune deficiency syndrome (AIDS) - United States. MMWR Morbidity and Mortality Weekly Report 1982;31:507-8, 513-4.
11. Centers for Disease Control and Prevention (CDC). Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR Morbidity and Mortality Weekly Report 1982;31:365-7.
12. Centers for Disease Control and Prevention (CDC). Unexplained immunodeficiency and opportunistic infections in infants - New York, New Jersey, California. MMWR Morbidity and Mortality Weekly Report 1982;31:665-7.
13. UNAIDS/WHO. A history of the HIV/AIDS epidemic with emphasis on Africa. In Workshop on HIV/AIDS and Adult Mortality in Developing Countries, Population Division, Department of Economic and Social Affairs, United Nations Secretariat, New York, 8-13 September 2003, Document UN/ POP/MORT/2003/2; 2003.
14. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71. (Pubitemid 13080157)
15. Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, Klatzmann D, Saimot AG, Rozenbaum W, et al. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1984;1:1253-6. (Pubitemid 14111079)
16. Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984;224:506-8. (Pubitemid 14134743)
17. Neurath AR, Strikc N, Sproul P, Baker L, Rubinstein P, Stevens CE, et al. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III). Journal of Virological Methods 1985;11:75-86. (Pubitemid 15044919)
18. Vogt MW, Witt DJ, Craven DE. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986;1:525-7. (Pubitemid 16113059)
19. Sprecher S, Soumerknoff G, Puissant F, Degueldre M. Vertical transmission of HIV in 15 week fetus. Lancet 1986;2:288-9. (Pubitemid 16098931)
20. Ziegler JB, Cooper DA, Johnson RO, Gold J. Post-natal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985;1:896-8. (Pubitemid 15009182)
21. Van de Perre P, Simonon A, Msellati P, Hitimana DG, Vaira D, Bazubagira A, et al. Post-natal transmission of human immunodeficiency virus type 1 from mother to infant. New England Journal of Medicine 1991;325:593-8.
22. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995;8:506-10.
23. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. New England Journal of Medicine 1987;317:185-91. (Pubitemid 17114872)
24. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New England Journal of Medicine 1994;331:1173-80. (Pubitemid 24331334)
25. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of motherto- child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802. (Pubitemid 29415583)
26. Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA:the Journal of the American Medical Association 2002;288:189-98. (Pubitemid 34755279)
27. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndromes 2002;29:484-4.
28. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. New England Journal of Medicine 2010;362:2271-81.
29. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, et al. Antiretroviral regimens in pregnancy and breastfeeding in Botswana. New England Journal of Medicine 2010;362:2282-94.
30. Fowler MG, Gable AR, Lampe MA, Etima M, Owor M. Perinatal HIV and its prevention: progress towards an HIV-free generation. Clinical Perinatology 2010;37:699-719.
31. Centers for Disease Control and Prevention (CDC). Racial/ ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004-2007. MMWR Morbidity and Mortality Weekly Report 2010;59:97-101.
32. Kourtis AP, Bulterys M. Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways. Clinical Perinatology 2010;37:721-37.
33. United Nations Children's Fund (UNICEF), UNAIDS, and WHO. Towards Universal Access: Scaling Up Priority HIV/ AIDS Interventions in the Health Sector. Progress Report 2010. UNICEF, New York, NY; 2010.
34. World Health Organization. Manual on Paediatric HIV care and Treatment for District Hospitals: Addendum to the Pocket Book of Hospital Care of Children. World Health Organization, Geneva; 2011.
35. World Health Organization. WHO Recommendations on the Management of Diarrhoea and Pneumonia in HIV-Infected Infants and Children: Integrated Management of Childhood Illness (IMCI). World Health Organization, Geneva; 2010.
36. Thea DM, St Louis ME, Atido U, Kanjinga K, Kenbo B, Matondo M, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. New England Journal of Medicine 1993;329:1696-702. (Pubitemid 23346920)
37. Chhagan MK, Kauchali S. Comorbidities and mortality among children hospitalized with diarrheal disease in an area of high prevalence of human immunodeficiency virus infection. Pediatric Infectious Disease Journal 2006;25:333-8.
38. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. British Journal of Nutrition 1999;81:181-9. (Pubitemid 29182183)
39. O'Brien DP, Sauvageot D, Olson D, Schaeffer M, Humblet P, Pudjades M, et al. Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clinical Infectious Diseases 2007;44:1245-8. (Pubitemid 46651252)
40. Jaspan HB, Berrisford AE, Boulle AM. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Pediatric Infectious Disease Journal 2008;27:993-8.
41. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008;371:243-60.
42. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics 2011;127:e423-41.
43. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA: the Journal of the American Medical Association 2007;298:1888-99. (Pubitemid 350005233)
44. Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, Inwani I, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatrics 2010;10:33.
45. Leyenaar JK, Novosad PM, Ferrer KT, Thahane LK, Mohapi EQ, Schutze GE, et al. Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in Lesotho. Pediatric Infectious Disease Journal 2010;39:340-5.
46. Fassinou P, Elenga N, Rouet F, Laguide R, Kouakoussui KA, Timite M, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Co○ te d'Ivoire. AIDS 2004;18:1905-13. (Pubitemid 39313206)
47. Nyandiko WM, Ayaya S, Nabakwe E, Tenge C, Sidle JE, Yiannoutsos CT, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. Journal of Acquired Immune Deficiency Syndromes 2006;43:418-25. (Pubitemid 44737098)
48. Weigel R, Phiri S, Chiputula F, Gumulira J, Brinkhof M, Gsponer T, et al. Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi. Tropical Medicine International Health 2010;15:934-44.
49. Musoke PM, Mudiope P, Barlow-Mosha LN, Ajuna P, Bagenda D, Mubiru MM, et al. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. BMC Pediatrics 2010;10:56.
50. Kabue MM, Kekintiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDs 2008;22:245-51. (Pubitemid 351380156)
51. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clinical Infectious Diseases 2005;41:100-7. (Pubitemid 40863751)
52. Naidoo R, Rennert W, Lung A, Naidoo K, McKerrow N. The influence of nutritional status on the response to HAART in HIV-infected children in South Africa. Pediatric Infectious Disease Journal 2010;29:511-3.
53. Sutcliffe CG, van Dijk JH, Munsanje B, Hamangaba F, Sinywinmaanzi P, Thuma PE, et al. Weight and height zscores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infectious Diseases 2011;11:54.
54. De Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food and Nutrition Bulletin 2010;31:S313-44.
55. De Pee W, Bloem MW. Current and potential role of specially formulated food and food supplements for preventing malnutrition among 6- to 23-month-old children and for treating moderate malnutrition among 6- to 59-month-old children. Food and Nutrition Bulletin 2009;30(3 Suppl.):S434-63.
56. Humphrey JH. The risk of not breastfeeding. Journal of Acquired Immune Deficiency Syndromes 2010;53:1-4.
57. Nduati RW, Johns G, Mbori-Ngacha DA, Richardson B, Overbaugh J, Ndinya-Achola J, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1. A randomised clinical trial. JAMA: the Journal of the American Medical Association 2000;283:1167-74. (Pubitemid 30126605)
58. Onyango-Makumbi C, Bagenda D, Mwatha A, Omer SB, Musoke P, Mmiro F, et al. Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. Journal of Acquired Immunodeficiency Syndromes 2010;53:20-7.
59. Homsy J, Moore D, Barasa A, Were W, Likicho C, Waiswa B, et al. Breastfeeding, mother-to-child HIV transmission and mortality among infants born to HIV-infected women on highly active antiretroviral therapy (HAART) in rural Uganda. Journal of Acquired Immunodeficiency Syndromes 2010;53:28-35.
60. Kafulafula G, Hoover DR, Taha ET, Thigpen M, Li Q, Fowler MG, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV- 1-uninfected children born to HIV-infected women in Malawi. Journal of Acquired Immunodeficiency Syndromes 2010;53:6-13.
61. Creek T, Kim A, Lu L, Masunge J, Arvelo W, Smit M, et al. Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. Journal of Acquired Immunodeficiency Syndromes 2010;53:14-9.
62. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. New England Journal of Medicine 2008;359:130-41. (Pubitemid 351962036)
63. Kuhn L, Sinkala M, Semrau K, Kankasa C, Kasonde P, Mwiya M, et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clinical Infectious Diseases 2010;50:437-44.
64. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. Lancet 1999;354:471-61.
65. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet 1999;354:471-6.
66. Donovan M, Palumbo P. Diagnosis of HIV: challenges and strategies for HIV prevention and detection among pregnant women and their infants. Clinical Perinatology 2010;37:751-63.
67. Camacho-Gonzalez AF, Ross AC, Chakraborty R. The clinical care of the HIV-1-infected infant. Clinical Perinatology 2010;37:873-85.
68. Robinson LG, Fernandez AD. Clinical care of the exposed infants of HIV-infected mothers. Clinical Perinatology 2010;37:863-72.
69. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine 2008;359:2233-44.
70. Paediatric European Network for Treatment of AIDS. Response to planned treatment interruptions in HIV infection varies across childhood. AIDS 2010;24:231-41.
71. Imada A, Yakoob MY, Sudfeld C, Haider BA, Black RE, Bhutta ZA. Impact of vitamin A supplementation on infant and childhood mortality. BMC Public Health 2011;11(Suppl. 3):S20.
72. Semba RD, Delange F. Iodine deficiency disorders. In: Semba RD, Bloem MW, editors. Nutrition and Health in Developing Countries, 2nd ed. Humana Press, Totowa, NJ; 2008. p. 507-29.
73. Baird SJ, Garfein RS, McIntosh CT, Özler B. Effect of cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet 2012;379:1320-9.
74. Sabery N, Duggan C. A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection. Journal of Parenteral and Enteral Nutrition 2009;33:588-606.
75. Rollins NC, van den Broeck J, Kindra G, Pent M, Kasambira T, Bennish ML. The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea. Acta Paediatrica 2007;96:62-8.
76. Ndekha MJ, Manary MJ, Ashorn P, Briend A. Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children. Acta Paediatrica 2005;94:222-5. (Pubitemid 40343699)
77. Amadi B, Mwiya M, Chomba E, Thomson M, Chintu C, Kelly P, et al. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition. Journal of Tropical Pediatrics 2005;51:5-10. (Pubitemid 40394186)
78. Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, et al. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Journal of Infectious Diseases 2009;200:1490-7.
79. World Health Organization. Guidelines on HIV and Infant Feeding. World Health Organization, Geneva; 2010.
80. Chantry CJ, Israel-Ballard K, Moldoveanu Z, Peerson J, Coutsoudis A, Sibeko L, et al. Effect of flash-heat treatment on immunoglobulins in breast milk. Journal of Acquired Immunodeficiency Syndromes 2009;51:263-7.
81. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107-16. (Pubitemid 46483637)
82. World Health Organization. Guidelines for an integrated approach to the nutritional care of HIV-infected children (6 months-14 years). In Handbook: Preliminary Version for Country Introduction. World Health Organization, Geneva; 2009.
83. UNAIDS. Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping their Mothers Alive. UNAIDS, Geneva; 2011.
84. De Pee S, Manary M, Ashorn P. The devil is in the details. Nutrition Reviews 2010;69:116-7.